American men are blowing their best chance to head off cancer or spot it early, when it's easiest to treat, a new survey warns.

More than 6 in 10 (65%) men in the nationwide survey said they are behind on at least one routine cancer screening, while nearly 1 in 5 admitted they don't even schedule their own health care appointments. 

Those are the key findings from the annual

MONDAY, July 1, 2024 (HealthDay news) -- A 14-year study of testicular cancer survivors suggests that a chemotherapy drug could greatly raise patients' long-term odds for hearing loss.

The drug in question, cisplatin, has been a mainstay of cancer chemotherapy for decades. It's often used to fight a range of cancers, including includ...

Some patients with early testicular cancer may not need chemotherapy and radiation, researchers report.

Instead, surgery to remove lymph nodes in an area behind the abdomen lining called the retroperitoneum may be enough, according to their new study.

"We found that the majority of participants in the study were cured with surgery alone, avoiding the toxicities associated with tra...

President Joe Biden announced Wednesday that he is giving a new push to the cancer moonshot initiative that he first led during the Obama administration.

In his announcement, Biden said the program would aim to boost prevention, screening and research with a target of reducing the cancer death rate by 50% over the ne...